Navigation Links
Dr. Philip A. DeFina of International Brain Research Foundation Joins Montgomery Academy Board of Trustees
Date:6/11/2009

Chester Township scientist, author and lecturer lends his expertise to special ed school

MENDHAM TOWNSHIP, N.J., June 11 /PRNewswire-USNewswire/ -- Montgomery Academy's Board of Trustees voted unanimously during its May meeting to name Dr. Philip A. DeFina to the Board of the nonprofit, state approved school.

Dr. DeFina founded the nonprofit International Brain Research Foundation and serves as both its Chief Executive Officer and Chief Scientific Officer. He has been a Guest Researcher at the National Institute of Health and a member of the International Neuroscience Subcommittee of the World Health Organization. A pioneer in developing and directing clinical training programs in the cognitive neurosciences, Dr. DeFina has worked to develop groundbreaking treatments for traumatic brain injury, coma, Alzheimer's, autism and Parkinson's. DeFina, himself an Army veteran, has revived over forty patients from minimally conscious or vegetative states including five injured U.S. soldiers. He has worked in collaboration with the Department of Defense and is the chief consultant for the traumatic brain injury program at Kessler Institute for Rehabilitation. His treatment protocols include electronic brain stimulation and hyperbaric oxygen induction, among other therapies, to help balance the electrical and chemical activity in the brain.

"It is a great honor to have Phil join Montgomery Academy's Board," said J. Anthony Manger of Norris, McLaughlin & Marcus, P.A., who chairs the Board of Trustees and also serves as an officer of its Foundation. "Phil's powerful and cutting edge work in neuroscience and brain health makes him particularly well suited to guide this gem of a school as it enters its 40th year of service to classified and autistic students. We are absolutely thrilled that he's accepted our invitation to join the Board and look forward to partnering with him to promote his vitally important brain research. Phil has written texts on educational neuropsychology and assessment and specializes in learning disabilities, psychiatric and autism spectrum disorders which affect Montgomery Academy students and many youngsters in our state."

Montgomery Academy delivers individualized instruction, counseling, transition, performing arts, athletics, technology, social skills and summer programs to students from over fifty sending districts in eight New Jersey counties. Its mission is to support and nurture youngsters who have emotional, behavioral and learning challenges that have not been met in conventional public school settings. It's a place where students can truly be themselves -- guided toward self-confidence, self-governance and self-knowledge in a reassuring atmosphere of trust and mutual respect. Making choices, cultivating interests: these are at the heart of the Montgomery Academy experience. To learn more about how Montgomery Academy creates opportunity for students with disabilities, please visit www.montgomeryacademyonline.org or call the school at 908.234.2840.


'/>"/>
SOURCE Montgomery Academy Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
2. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
3. Audio from Medialink and Philips: Americas Dirty Mouths
4. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
5. AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush
6. North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign
7. Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
8. Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use
9. Philip Coelho Joins Mediware Board
10. VIDEO from Medialink and Philips: Philips Electronics Unveils First Imagination Light Canvas at the New Mercy Medical Center in Rogers AR
11. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... Footwear Foundation, the national charitable foundation serving the footwear industry, has broken all ... representing more than 130 companies across 23 states during the months of April ...
(Date:4/29/2016)... Georgia (PRWEB) , ... April 29, 2016 , ... On ... rural hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB ... Rep. Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and ...
(Date:4/29/2016)... STAMFORD, CONNECTICUT (PRWEB) , ... April 29, 2016 , ... ... 5K Run/Walk” at Cove Island Park on Sunday, with sunny skies, a light breeze ... event, raising nearly $33,000. , The 5k Run and Walk and 1-mile ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton School of ... Grand Prize of the 2016 Wharton Business Plan Competition —as well as ... Award, and the Committee Award for Most ‘Wow Factor,’ making them the first ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. ... for the majority of skin cancer deaths. More than 10,000 people are expected to die ... diagnosis is 62, it is the one of the most commonly diagnosed cancers in young ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Dr. ... und Stephen Schmidt werden Teil ... ein führender Anbieter cloudbasierter Softwarelösungen für den ... neue Führungskräfte zum Team Sicherheit und Pharmakovigilanz ... Erfahrungen mitbringen.  Dies wird die Geschäftseinheit Sicherheit ...
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/27/2016)...  Hologic, Inc. (Nasdaq: HOLX ) ... fiscal second quarter ended March 26, 2016.  GAAP ... 41.2%, and non-GAAP diluted EPS of $0.47 increased ... a reported basis, and 6.3% on a constant ... good quarter, highlighted by 14.6% growth in non-GAAP ...
Breaking Medicine Technology: